Collaboration - March 20, 2015
WHO: Nations Must Cooperate
According to a new study from the World Health Organization (WHO), European countries need to consider working together more to afford new, more expensive pharmaceuticals entering the market. New therapies for chronic conditions like cancer, Type 2 diabetes and hepatitis C have come onto the scene—with hefty pricetags. “While these therapies are straining budgets across […]
Collaboration - March 20, 2015
AstraZeneca, Daiichi Sankyo Ink Co-Commercialization Deal
AstraZeneca Thursday signed a co-commercialization agreement with Parsippany, N.J.-based Daiichi Sankyo, Inc. worth $825 million. According to the agreement, Daiichi Sankyo will pay AstraZeneca $200 million upfront and follow-up payments up to $625 million to handle manufacturing and sales of Movantik (naloxegol), a once-daily pill for people with opioid-induced constipation (OIC). AstraZeneca will oversee manufacturing […]
Collaboration - March 19, 2015
U.S. Company Comes to Karolinska
The American research company Modern Therapeutics has moved into an operations base in the Karolinska Institutet Science Park, Kisp, in Flemingsberg. This will give the the researchers closer contact with the scientists at Karolinska Institutet and Karolinska University Hospital. “We will start with test ideas preclinically together with researchers at Karolinska Institutet first. Then we […]
Collaboration - March 13, 2015
AZ Invests in PhaseBio Trial
PhaseBio Pharmaceuticals, Inc. a biopolymer-based drug manufacturer, has raised $40 million in a Series C round of funding, which includes a major share from AstraZeneca. Existing investors New Enterprise Associates, Hatteras Venture Partners and Johnson & Johnson Innovation were also involved in the financing round, according to BioSpace. “AstraZeneca is committed to bringing innovative treatments […]
Collaboration - March 12, 2015
Artists, Scientists Share Space
Swedish artists and scientists are forming a community through the Artreslab project, taking shape in the Haga district linking Stockholm and Solna. One aim of the project is to explore the boundaries and build bridges between scientific and artistic research, says Elisabeth Wade, head of the art Division at the Stockholm County Council’s Culture Committee. […]
Collaboration - February 26, 2015
AstraZeneca, Orca Sign Pact
British biotech startup Orca got $122.5 million from AstraZeneca PLC after the two companies signed a three-year research agreement to develop Orca’s retinoic acid-related orphan nuclear receptor gamma inhibitors. Orca is slated to receive upfront and milestone payments from AstraZeneca, depending on the success of its RORϒ inhibitors in the program. There is potential for […]
